Panbio COVID-19/Flu A&B Rapid Panel

Panbio™ COVID-19/Flu A&B Rapid Panel (Nasopharyngeal)

differential diagnosis enables timely treatment decisions

COVID-19 and Influenza have similar symptoms, making differential diagnosis difficult. Using one nasopharyngeal swab, the Panbio™ COVID-19/Flu A&B Rapid Panel simultaneously tests for COVID-19, Influenza A, and Influenza B, with results in 15 minutes. Ideal for testing many people quickly in general practice offices, point-of-care sites, workplaces, pharmacies, and schools/universities. Make actionable decisions quickly to help prevent the spread of illness.

Benefits

Swift, Targeted Decisions

Accelerate patient management with clear, actionable diagnoses.

Quick Contagion Identification

Rapidly flag infectious cases to optimize treatment and containment.

Scalable, High-Volume Testing

Seamlessly integrate into large-scale testing workflows without disruption.

Symptom-Driven Diagnosis

Designed for precise detection in patients presenting COVID-19 or Flu A/B symptoms.

Single Swab, Dual Results

Simplify diagnostics with one swab covering both COVID-19 and Flu A/B.

Results in 15 minutes

Nasopharyngeal swab

Pre-filled buffer extraction tubes

Storage: 2°C–30°C

10 Test Kit Contents:

-10 Test devices

-10 Extraction buffer tubes

-10 Nozzle caps

-Sterilized nasopharyngeal swabs for specimen collection

-1 Tube rack

-1 Instructions for Use with Quick Reference Guide

Positive Controls Kit Contents:

-10 Positive Control Swabs

- 1 Instructions for Use with Quick Reference Guide

CE Mark

VIDEOS

TEST PROCEDURE LIVE ACTION

Watch a live demonstration of the procedure.

TEST PROCEDURE ANIMATION

How to run a Panbio™ Covid-19/ Flu A&B Rapid Panel.

What's in the box?

Simple kit contents make testing easy.

Differential diagnosis

Make treatment decisions in time to make a difference.

Determine™ HBsAg 2

The world's most sensitive rapid test for detecting hepatitis B surface antigen in serum, plasma, or whole blood.

WHO evaluations show most rapid tests have an analytical sensitivity of 2–10 IU/mL. Until now, no rapid test for plasma, serum, and whole blood met the EU and WHO requirement of 0.13 IU/mL.

Determine™ HBsAg 2 offers exceptional sensitivity at 0.1 IU/mL, providing a fast, accurate lateral flow test for detecting HBsAg. Its ease of use enhances HBV case detection, ensuring timely patient care across diverse healthcare settings.

Not available in all countries. Not approved for sale in the USA.

Benefits

Enhances Case Finding: Enables broader HBV detection.
Early Detection, Better Outcomes: Identifies infection sooner for timely care.
Rapid Results, Reduced Loss to Follow-Up: Quick turnaround minimizes missed cases.
Easy to Use: No special training or lab equipment needed.
Flexible Sample Options: Works with serum, plasma, or whole blood.
Detects Major HBsAg Mutants: See Product Insert for details.
Versatile for Any Setting: Suitable for various healthcare environments.